Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof
US-12053468-B2 · Aug 6, 2024 · US
Acetylon Pharmaceuticals Inc holds 80 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 80 |
| Recent patents | 6 |
| First publication | Apr 9, 2015 |
| Latest publication | Aug 6, 2024 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12053468-B2 · Aug 6, 2024 · US
US-11998546-B2 · Jun 4, 2024 · US
US-11872227-B2 · Jan 16, 2024 · US
US-2023364083-A1 · Nov 16, 2023 · US
US-11813261-B2 · Nov 14, 2023 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12053468-B2 · Aug 6, 2024 · US
US-11998546-B2 · Jun 4, 2024 · US
US-11872227-B2 · Jan 16, 2024 · US
US-2023364083-A1 · Nov 16, 2023 · US
US-11813261-B2 · Nov 14, 2023 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 63 |
| A61K31/505 | 56 |
| C07D239/42 | 37 |
| A61P43/00 | 35 |
| A61K45/06 | 30 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 77 |
| Chemistry & Metallurgy | 65 |
| Physics | 3 |
Answers are generated from the same data shown on this page.